ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Dark Blue Therapeutics Ltd

Dark Blue Therapeutics Ltd is an active company incorporated on 4 June 2020 with the registered office located in Oxford, Oxfordshire. Dark Blue Therapeutics Ltd was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12645831
Private limited company
Age
5 years
Incorporated 4 June 2020
Size
Large
Did not meet the 2-out-of-3 criteria for Medium size or smaller.
Confirmation
Submitted
Dated 3 June 2025 (7 months ago)
Next confirmation dated 3 June 2026
Due by 17 June 2026 (5 months remaining)
Last change occurred 7 months ago
Accounts
Submitted
For period 1 Jul30 Jun 2024 (1 year)
Accounts type is Small
Next accounts for period 30 June 2025
Due by 31 March 2026 (2 months remaining)
Contact
Address
Hayakawa Building, Edmund Halley Road
The Oxford Science Park
Oxford
OX4 4GB
United Kingdom
Address changed on 12 Mar 2023 (2 years 10 months ago)
Previous address was Hayakawa Edmund Halley Road the Oxford Science Park Oxford Oxfordshire OX4 4GB United Kingdom
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
1
Shareholders
23
Controllers (PSC)
1
Director • British • Lives in England • Born in Jul 1970
Oxford Science Enterprises Plc
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Amgen Limited
Christopher Paul Walker is a mutual person.
Active
Kleidox Therapeutics Ltd
Christopher Paul Walker is a mutual person.
Active
Biovex Limited
Christopher Paul Walker is a mutual person.
Dissolved
Horizon Therapeutics UK Limited
Christopher Paul Walker is a mutual person.
Dissolved
Amgen Global Manufacturing Ltd
Christopher Paul Walker is a mutual person.
Dissolved
Amgen Global Technology Ltd
Christopher Paul Walker is a mutual person.
Dissolved
Brands
Dark Blue Therapeutics
Dark Blue Therapeutics is a biotechnology company that develops therapeutic solutions.
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Period Ended
30 Jun 2024
For period 30 Jun30 Jun 2024
Traded for 12 months
Cash in Bank
£11.66M
Increased by £3.97M (+52%)
Turnover
Unreported
Same as previous period
Employees
13
Increased by 6 (+86%)
Total Assets
£12.31M
Increased by £3.99M (+48%)
Total Liabilities
-£834K
Decreased by £8.2M (-91%)
Net Assets
£11.47M
Increased by £12.19M (-1696%)
Debt Ratio (%)
7%
Decreased by 101.87% (-94%)
Latest Activity
Amgen Uk Holdings Limited (PSC) Details Changed
8 Days Ago on 30 Dec 2025
Mr Christopher Paul Walker Details Changed
8 Days Ago on 30 Dec 2025
Edwin Moses Resigned
8 Days Ago on 30 Dec 2025
Bms Strategic Portfolio Investments Holdings, Inc. (PSC) Resigned
8 Days Ago on 30 Dec 2025
Oxford Science Enterprises Plc (PSC) Resigned
8 Days Ago on 30 Dec 2025
Amgen Uk Holdings Limited (PSC) Appointed
8 Days Ago on 30 Dec 2025
Emma Smith Resigned
8 Days Ago on 30 Dec 2025
Justian Craig Fox Resigned
8 Days Ago on 30 Dec 2025
James Carmichael Resigned
8 Days Ago on 30 Dec 2025
Thomas Hanke Resigned
8 Days Ago on 30 Dec 2025
Get Credit Report
Discover Dark Blue Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Termination of appointment of Alastair Graham Mackinnon as a director on 30 December 2025
Submitted on 5 Jan 2026
Appointment of Mr Christopher Paul Walker as a director on 30 December 2025
Submitted on 5 Jan 2026
Termination of appointment of Thomas Hanke as a director on 30 December 2025
Submitted on 5 Jan 2026
Termination of appointment of James Carmichael as a director on 30 December 2025
Submitted on 5 Jan 2026
Termination of appointment of Justian Craig Fox as a director on 30 December 2025
Submitted on 5 Jan 2026
Termination of appointment of Emma Smith as a secretary on 30 December 2025
Submitted on 5 Jan 2026
Notification of Amgen Uk Holdings Limited as a person with significant control on 30 December 2025
Submitted on 5 Jan 2026
Change of details for Amgen Uk Holdings Limited as a person with significant control on 30 December 2025
Submitted on 5 Jan 2026
Director's details changed for Mr Christopher Paul Walker on 30 December 2025
Submitted on 5 Jan 2026
Termination of appointment of Edwin Moses as a director on 30 December 2025
Submitted on 5 Jan 2026
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year